Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 20.40
-0.40 (-1.92%)
At close: Oct 21, 2025
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 117.66 million as of October 21, 2025. Its market cap has decreased by -29.34% in one year.
Market Cap
117.66M
Enterprise Value
265.17M
Revenue
839.38K
Ranking
n/a
PE Ratio
4.49
Stock Price
20.40
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 117.66M, a decrease of -51.07%. That is a compound annual growth rate of -17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 119.97M | -17.74% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 243.21B |
| Novartis AG | 201.75B |
| Lonza Group AG | 38.88B |
| Galderma Group AG | 32.50B |
| Alcon | 29.43B |
| Sandoz Group AG | 20.85B |
| Straumann Holding AG | 13.86B |
| Sonova Holding AG | 12.96B |